SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

Prior Bariatric Surgery Lowers Postop Risk Over GLP-1s

Another Pregnancy Can Worsen Insulin Sensitivity Over Time

In parous women, an additional pregnancy is linked to a selective decline in whole-body insulin sensitivity over 10 years, with no clear changes in beta-cell function or blood glucose levels.

Tirzepatide Effective Despite Weight-Inducing Meds

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

US FDA Clarifies Policies on Compounding Of GLP-1 Medicines

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Analysis Links RAI Therapy to Breast Cancer Risk

Clinicians may want to discuss radioactive iodine therapy’s potential for increasing breast cancer risk with patients undergoing hyperthyroidism treatment, researchers say.

Immunovant's Treatment for Eye Disease Fails in Late-stage Trials

Immunovant said on Thursday that its therapy failed to reduce eye bulging ⁠when tested in patients with moderate-to-severe thyroid eye disease in two late-stage...

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Latest News

In parous women, an additional pregnancy is linked to a selective decline in whole-body insulin sensitivity over 10 years, with no clear changes in beta-cell function or blood glucose levels.

Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.

The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ⁠popular GLP-1 drugs, signaling tighter limits on their production as...

Clinicians may want to discuss radioactive iodine therapy’s potential for increasing breast cancer risk with patients undergoing hyperthyroidism treatment, researchers say.

Immunovant said on Thursday that its therapy failed to reduce eye bulging ⁠when tested in patients with moderate-to-severe thyroid eye disease in two late-stage...

News All Time

EMA Clears New First-Line Options for Advanced Cancers

European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.

NICE Introduces Endometriosis Fertility Pathway

An updated NICE guideline sets out a dedicated pathway for endometriosis within wider fertility guidance.

Weight Loss May Cut Cancer Risk in Adults With Obesity

Nonsurgical weight loss is associated with reduced incident risks for both obesity-related and other cancers in adults with obesity.

Medtronic Gets US FDA Nod to Use Surgical System in Cranial, ENT Surgeries

Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system ⁠for cranial and ear, nose and throat procedures, expanding the platform...

EU Reaffirms Rejection of Rare Sleep Disorder Drug

The sleep drug failed to gain approval for nighttime disruptions in children with a rare genetic disorder affecting circadian rhythm patterns.

Experts Question Evidence for New Testosterone Advice

New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.

Once- or Twice-Yearly Injection for Weight Loss?

Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

Do ESAs for Anemia Raise Cancer Risk in Dialysis Patients?

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

Ontario Government Proposes New Integrated EMR System

As Ontario proposes a new connected primary care medical record system, healthcare advocates are hoping to avoid the perils of previous attempts.

FDA Approves First Once-Weekly Insulin for Type 2 Diabetes

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

US FDA Approves Novo's Insulin Injection for Type 2 Diabetes

The U.S. Food and Drug ⁠Administration has approved Novo Nordisk's insulin injection, ⁠Awiqli, to control blood sugar levels ⁠in adults ‌living with type 2 diabetes, the...

Dad’s Nicotine Use May Shape Kids’ Metabolic Health

Paternal nicotine use alters metabolism in offspring, and those changes are sex-specific, a study in mice shows.

Dementia Risk May Triple With Type 1 Diabetes

The risk for dementia is significantly higher in people with diabetes, with the greatest risk among those with type 1 disease, new research shows.

Does Eating the Same Foods Work Best for Weight Loss?

Repeating the same meals and keeping calorie intake steady produces more weight loss than eating a more varied diet among individuals living with overweight or obesity.

Elinzanetant Reduces Vasomotor Symptoms in Breast Cancer

Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of type of endocrine treatment used.

Germany Renews Push for Sugar Tax & Energy Drinks Ban for Kids

A German push to tax sugary drinks and ban energy drinks for under-16s will be voted on by the country's assembly of regional states on Friday.

Recommended News For You

Study suggests exercise could reduce breast cancer recurrence

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Cancer cells with thick glycocalyx barrier evade immune system better: study

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

After two years, a significant left nasal obstruction was finally diagnosed.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

Recommended Articles For You

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management 

Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation 

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies 

From Bench to Bedside: The New Era of Lymphoma Treatment and Education 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Screening tests that are non-invasive show promise in detecting colorectal cancer.

2.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

3.

Why are so many young adults getting cancer?

4.

Liquid Biopsy for Colorectal Cancer Screening Might Not Be Ready for Prime Time.

5.

Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.

1.

Seeing the Unseen: Examining Chancroid Through Images

2.

Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies

3.

Emerging and Innovative Therapies in Cancer Treatment and Post-Surgical Care

4.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

5.

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

5.

Navigating the Complexities of Ph Negative ALL - Part XIV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot